McGill team funded as part of a $4.5 million national investment dedicated to identifying genomic solutions to counter antimicrobial resistance and prepare for future pandemics
Multidisciplinary unit to focus on rise of ‘superbugs’ identified by WHO as a leading threat to global health, responsible for 700,000 annual deaths worldwide
October 20, 2021 (Montreal, Quebec) – Globally, Antimicrobial Resistance (AMR) causes approximately 700,000 deaths annually, a number projected to reach over 10 million yearly deaths by 2050. The prevalence of AMR in Canada is projected to reach 40% by this time, a plausible scenario if no interventions successfully curb their rise.
On May 3, the Natural Sciences and Engineering Research Council (NSERC) announced the recent recipients of the NSERC Strategic Partnership Grants program. Six McGill-led projects in the Faculty of Engineering and one in the Faculty of Medicine are receiving more than $3.7 million to conduct research in collaboration with a supporting organization.

